ID

33331

Beschrijving

Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains informations about any recorded neurological abnormalities during the study. It should be filled out everytime a neurological examination is performed.

Trefwoorden

Versies (2)

1. 05-12-18 05-12-18 -
2. 28-01-19 28-01-19 - Sarah Riepenhausen

Houder van rechten

GlaxoSmithKline

Geüploaded op

5 december 2018

DOI

Voor een aanvraag inloggen.

Licentie